To confirm the inhibition of cancer stemness by silibinin, qPCR was conducted to check the expression of specific CSC markers (SOX2, OCT4, and NANOG), and significant inhibition of these stem cell markers by silibinin has been noted (Figure 4B). The gene discussed is SOX2; the disease is cancer.